@article{ebd37a7cad4b4fee9e7224e5392c04a4,
title = "Low-dose vemurafenib monotherapy in BRAFV600E-mutated Erdheim-Chester disease",
author = "{on behalf of the Mayo Clinic Histiocytosis Working Group} and Ruan, {Gordon J.} and Antonious Hazim and Abeykoon, {Jithma P.} and Caleb Scheckel and Robert Vassallo and Ryu, {Jay H.} and Tobin, {W. Oliver} and Koster, {Matthew J.} and Bennani, {N. Nora} and Rech, {Karen L.} and Young, {Jason R.} and Shah, {Mithun V.} and Gaurav Goyal and Go, {Ronald S.}",
note = "Funding Information: This work was supported in part by the University of Iowa/Mayo Clinic Lymphoma SPORE CA97274.",
year = "2020",
month = nov,
doi = "10.1080/10428194.2020.1783447",
language = "English (US)",
volume = "61",
pages = "2733--2737",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "11",
}